Catherine Richon

2.7k total citations
32 papers, 1.2k citations indexed

About

Catherine Richon is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Catherine Richon has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Catherine Richon's work include Cancer Genomics and Diagnostics (10 papers), Cell death mechanisms and regulation (5 papers) and Cancer-related Molecular Pathways (5 papers). Catherine Richon is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Cell death mechanisms and regulation (5 papers) and Cancer-related Molecular Pathways (5 papers). Catherine Richon collaborates with scholars based in France, United States and Switzerland. Catherine Richon's co-authors include Philippe Dessen, Vladimir Lazar, Salem Chouaı̈b, Bastien Job, Gilles Vassal, Abdelali Jalil, Fathia Mami‐Chouaib, Fabrice André, Stefan Michiels and Suzette Delaloge and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Catherine Richon

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine Richon France	18	608	419	391	243	233	32	1.2k
Andrew J. Tsung United States	25	706 1.2×	495 1.2×	352 0.9×	284 1.2×	366 1.6×	54	1.5k
Yvonne T.M. Tsang United States	18	533 0.9×	211 0.5×	329 0.8×	166 0.7×	148 0.6×	24	1.2k
Vinay Sagar United States	19	712 1.2×	231 0.6×	361 0.9×	142 0.6×	190 0.8×	46	1.3k
Janna Paulsson Sweden	19	748 1.2×	398 0.9×	703 1.8×	217 0.9×	133 0.6×	21	1.5k
Julie Koeman United States	20	923 1.5×	462 1.1×	365 0.9×	93 0.4×	128 0.5×	26	1.5k
Sara Akhavanfard United States	8	801 1.3×	504 1.2×	356 0.9×	75 0.3×	340 1.5×	15	1.4k
Yuexi Shi United States	14	837 1.4×	254 0.6×	563 1.4×	226 0.9×	283 1.2×	27	1.3k
Dirk Kemming Germany	15	683 1.1×	504 1.2×	423 1.1×	134 0.6×	312 1.3×	22	1.3k
Caroline Delmas France	22	794 1.3×	433 1.0×	408 1.0×	139 0.6×	343 1.5×	37	1.4k
Alexandra Florin Germany	19	691 1.1×	302 0.7×	388 1.0×	123 0.5×	73 0.3×	27	1.1k

Countries citing papers authored by Catherine Richon

Since Specialization

Citations

This map shows the geographic impact of Catherine Richon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Richon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Richon more than expected).

Fields of papers citing papers by Catherine Richon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Richon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Richon. The network helps show where Catherine Richon may publish in the future.

Co-authorship network of co-authors of Catherine Richon

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Richon. A scholar is included among the top collaborators of Catherine Richon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Richon. Catherine Richon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Auguste, Aurélie, Félix Blanc‐Durand, Marc Deloger, et al.. (2020). Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis. Cells. 9(6). 1496–1496. 31 indexed citations

Tran-Dien, Alicia, Jérôme Lemonnier, Florence Dalenc, et al.. (2019). Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studies. Breast Cancer Research and Treatment. 179(2). 387–401. 10 indexed citations

Dmitriev, Petr, Catherine Richon, Philippe Dessen, et al.. (2015). Correction of the FSHD myoblast differentiation defect by fusion with healthy myoblasts. Journal of Cellular Physiology. 231(1). 62–71. 11 indexed citations

Truffaux, Nathalène, Cathy Philippe, Janna Paulsson, et al.. (2014). Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma. Neuro-Oncology. 17(7). 953–964. 51 indexed citations

Arnedos, Mónica, Véronique Scott, Bastien Job, et al.. (2012). Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: A clinical experience in 108 patients with metastatic breast cancer. European Journal of Cancer. 48(15). 2293–2299. 18 indexed citations

Puget, Stéphanie, Cathy Philippe, Dorine A. Bax, et al.. (2012). Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas. PLoS ONE. 7(2). e30313–e30313. 169 indexed citations

Meslin, Franck, Ahmed Hamaï, Bernhard Mlecnik, et al.. (2011). hSMG-1 is a granzyme B-associated stress-responsive protein kinase. Journal of Molecular Medicine. 89(4). 411–421. 7 indexed citations

Dessen, Philippe, Nathalie Auger, Claude Preudhomme, et al.. (2011). Chromosomal Minimal Critical Regions in Therapy-Related Leukemia Appear Different from Those of De Novo Leukemia by High-Resolution aCGH. PLoS ONE. 6(2). e16623–e16623. 22 indexed citations

Thomas, Laurent F., Silvia Anna Ciafrè, Guillaume Meurice, et al.. (2011). Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma. British Journal of Cancer. 105(9). 1352–1361. 88 indexed citations

10.

Scott, Véronique, Catherine Richon, Mario Campone, et al.. (2010). High-throughput technologies to personalize medical treatment in patients with metastatic breast cancer.. Journal of Clinical Oncology. 28(15_suppl). 1047–1047. 1 indexed citations

11.

André, Fabrice, Bastien Job, Philippe Dessen, et al.. (2009). Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array. Clinical Cancer Research. 15(2). 441–451. 248 indexed citations

12.

Noman, Muhammad Zaeem, Stéphanie Buart, Jos van Pelt, et al.. (2009). The Cooperative Induction of Hypoxia-Inducible Factor-1α and STAT3 during Hypoxia Induced an Impairment of Tumor Susceptibility to CTL-Mediated Cell Lysis. The Journal of Immunology. 182(6). 3510–3521. 144 indexed citations

13.

Olaussen, Ken A., Frédéric Commo, Maximilien Tailler, et al.. (2009). Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines. Oncogene. 28(48). 4249–4260. 48 indexed citations

14.

Dessen, Philippe, Gisèle Danglot, Catherine Richon, et al.. (2009). High Resolution Genome-Wide Analysis of Chromosomal Alterations in Burkitt's Lymphoma. PLoS ONE. 4(9). e7089–e7089. 45 indexed citations

15.

Chansac, Béatrice Le Maux, Dorothée Missé, Catherine Richon, et al.. (2008). Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway. International Immunology. 20(7). 801–810. 24 indexed citations

16.

Meslin, Franck, Jérôme Thiery, Catherine Richon, Abdelali Jalil, & Salem Chouaı̈b. (2007). Granzyme B-induced Cell Death Involves Induction of p53 Tumor Suppressor Gene and Its Activation in Tumor Target Cells. Journal of Biological Chemistry. 282(45). 32991–32999. 34 indexed citations

17.

Bernheim, Alain, Marine Guillaud-Bataille, Catherine Richon, et al.. (2007). Intragenic breakpoints localized by array CGH in a t(2;6) familial translocation. Cytogenetic and Genome Research. 119(3-4). 185–190. 4 indexed citations

18.

Hamaï, Ahmed, Catherine Richon, Franck Meslin, et al.. (2006). Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: relationship to Bcl-2 family and caspase activation. Oncogene. 25(58). 7618–7634. 42 indexed citations

19.

Thiery, Jérôme, Guillaume Dorothée, Abdelali Jalil, et al.. (2005). p53 Potentiation of Tumor Cell Susceptibility to CTL Involves Fas and Mitochondrial Pathways. The Journal of Immunology. 174(2). 871–878. 24 indexed citations

20.

Thiery, Jérôme, Guillaume Dorothée, Hédi Haddada, et al.. (2003). Potentiation of a Tumor Cell Susceptibility to Autologous CTL Killing by Restoration of Wild-Type p53 Function. The Journal of Immunology. 170(12). 5919–5926. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact